Federated Hermes, Inc. Olema Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.19 - $12.98 $2,432 - $3,855	-297 Reduced 22.3%	1,035 $12,000
Q2 2023 Aug 14, 2023	SELL	$3.22 - $9.65 $1,213 - $3,638	-377 Reduced 22.06%	1,332 $12,000
Q1 2023 May 08, 2023	SELL	$2.55 - $4.97 $4,755 - $9,269	-1,865 Reduced 52.18%	1,709 $5,000
Q4 2022 Feb 13, 2023	BUY	$2.27 - $3.76 $1,527 - $2,530	673 Added 23.2%	3,574 $8,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.88 $4,526 - $9,784	-1,664 Reduced 36.45%	2,901 $8,000
Q2 2022 Aug 15, 2022	BUY	$2.04 - $4.61 $4,294 - $9,704	2,105 Added 85.57%	4,565 $19,000
Q1 2022 May 13, 2022	BUY	$3.89 - $9.43 $9,160 - $22,207	2,355 Added 2242.86%	2,460 $10,000
Q4 2021 Feb 14, 2022	SELL	$8.75 - $30.71 $2.27 Million - $7.98 Million	-259,895 Reduced 99.96%	105 $1,000
Q4 2020 Feb 12, 2021	BUY	$37.09 - $54.5 $9.64 Million - $14.2 Million	260,000 New	260,000 $12.5 Million

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $247M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.